CAD 0.01
(N/A%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 25.4 Thousand CAD | 769.96% |
2022 | -3792.00 CAD | 24.13% |
2021 | -4998.00 CAD | -389.07% |
2020 | 1729.00 CAD | 6.33% |
2019 | 1626.00 CAD | 118.8% |
2018 | -8647.00 CAD | -186.7% |
2017 | -3016.00 CAD | -412.93% |
2016 | -588.00 CAD | 8.27% |
2015 | -641.00 CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | -100.0% |
2005 | 488.00 CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -577.00 CAD | 0.17% |
2024 Q1 | -578.00 CAD | 98.01% |
2023 Q2 | -735.00 CAD | 0.0% |
2023 Q1 | -735.00 CAD | 22.47% |
2023 Q4 | -29.08 Thousand CAD | -205.33% |
2023 Q3 | 27.61 Thousand CAD | 3856.46% |
2023 FY | 25.4 Thousand CAD | 769.96% |
2022 Q4 | -948.00 CAD | 0.0% |
2022 FY | -3792.00 CAD | 24.13% |
2022 Q1 | -948.00 CAD | 24.16% |
2022 Q2 | -948.00 CAD | 0.0% |
2022 Q3 | -948.00 CAD | 0.0% |
2021 Q4 | -1250.00 CAD | -0.08% |
2021 FY | -4998.00 CAD | -389.07% |
2021 Q3 | -1249.00 CAD | 38.86% |
2021 Q2 | -2043.00 CAD | -348.03% |
2021 Q1 | -456.00 CAD | -936.36% |
2020 Q4 | -44.00 CAD | -269.23% |
2020 Q1 | 1204.00 CAD | -25.95% |
2020 FY | 1729.00 CAD | 6.33% |
2020 Q2 | 543.00 CAD | -54.9% |
2020 Q3 | 26.00 CAD | -95.21% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q4 | 1626.00 CAD | 0.0% |
2019 FY | 1626.00 CAD | 118.8% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 FY | -8647.00 CAD | -186.7% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | -3016.00 CAD | -412.93% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 100.0% |
2017 Q4 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 FY | -588.00 CAD | 8.27% |
2016 Q2 | - CAD | 0.0% |
2016 Q4 | -724.73 Thousand CAD | 0.0% |
2015 FY | -641.00 CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q1 | 3599.00 CAD | 0.0% |
2007 Q3 | - CAD | -100.0% |
2007 Q2 | 5581.00 CAD | 55.07% |
2007 FY | - CAD | 0.0% |
2006 Q3 | 295.00 CAD | 100.68% |
2006 FY | - CAD | -100.0% |
2006 Q1 | 148.00 CAD | 0.0% |
2006 Q4 | - CAD | -100.0% |
2006 Q2 | 147.00 CAD | -0.68% |
2005 FY | 488.00 CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 150.409% |
Asep Medical Holdings Inc | -113.74 Thousand CAD | 122.336% |
BetterLife Pharma Inc. | - CAD | -Infinity% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | -42 Thousand CAD | 160.488% |
Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 95.491% |
Defence Therapeutics Inc. | -90.92 Thousand CAD | 127.941% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 89.851% |
Gemina Laboratories Ltd. | -93.36 Thousand CAD | 127.21% |
Glow Lifetech Corp. | -505.62 Thousand CAD | 105.024% |
Lexston Life Sciences Corp. | -26.39 Thousand CAD | 196.253% |
Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 94.405% |
Doseology Sciences Inc. | -36.08 Thousand CAD | 170.405% |
MYND Life Sciences Inc. | -332.99 Thousand CAD | 107.629% |
PharmaTher Holdings Ltd. | -711.00 CAD | 3673.136% |
PreveCeutical Medical Inc. | -9856.00 CAD | 357.762% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 95.733% |